International Business Machines (IBM)
TL;DR
IBM is a hybrid-cloud and enterprise-AI platform — Red Hat, watsonx orchestration and governance, consulting, and mainframe infrastructure — a direct AI beneficiary built on trust, neutrality, and control. Just reported: Q2 FY2026 revenue $17.2B (+1%), operating EPS $2.93 (+5%), margin 19.2% — a MISS as large mainframe/ELA deals slipped. The FY revenue guide was cut to +4–5% but 100bps of margin expansion and FCF +$1B held — deferred, not lost. Stock at $206 with 17x P/E(ttm) after a ~27% drop — cheap for an 80%-recurring-software, high-FCF, ~4% dividend name with AI/quantum optionality.
Summary
| Finding | Assessment |
|---|---|
| 5-Year Stock Return | ~$140→$206 (+47%). TTM OP +47% (~$9.0B→$13.2B), operating non-GAAP basis. P/E(ttm) stable ~16–17x (range ~9–28x). |
| Business Model | Software-led hybrid cloud + AI. Software ~45%, Consulting ~31%, Infrastructure ~22%. ARR $24.6B (+8%). |
| Competitive Moat | NARROW Mainframe lock-in (6-8 nines uptime), Red Hat OpenShift $2B ARR, watsonx for regulated AI. Consulting faces AI automation risk. |
| Past 5-YR Drivers | Software pivot (Red Hat, HashiCorp, Confluent), Z17 strongest mainframe cycle ever (+48%), $4.5B AI productivity savings. |
| Recent Stock Move | $206, down ~27% from the ~$281 June-30 close on the pre-announced Q2 miss (deals slipped). P/E(ttm) 17x. Deferred, not lost — about a third re-closed in early Q3. |
| Revenue Trend | ACCELERATING Rev YoY: 1% (Q2 2026) → 3% (Q3 2026E). |
| Margin Trend | FLAT OM%: 19% (Q2 2026) → 19% (Q3 2026E). |
| TTM OP Trajectory | FLAT TTM OP QoQ: 1% (Q2 2026) → 1% (Q3 2026E). TTM OP $13.2B. |
| Key Opportunities | AI orchestration/governance (watsonx Orchestrate + Red Hat neutrality). Recurring software compounding (ARR $24.6B +8%, ~80% recurring, Red Hat +11%). Quantum ($10B, fault-tolerant 2029) + z17/Spyre + Lightwell. |
| Key Risks | Execution/deal-timing risk (the Q2 ELA/mainframe slippage). Slow ~4–5% growth + mainframe cyclicality (TP −9%, IBM Z −42%). AI-orchestration thesis unproven at scale; hyperscaler/SaaS competition. |
| Catalysts | Re-close of slipped deals + FY +4–5% cc execution. 100bps operating-margin expansion + FCF +$1B. z17 cycle (~130% prog-to-prog) + Distributed Infra (+37%). Quantum milestones; Lightwell adoption. |
| P/E(ttm) Valuation | 17x for a low-growth but high-FCF (80%+ conversion), ~80%-recurring-software name with a ~4% dividend — reasonable to cheap after the ~27% drop. Re-rates higher if slipped demand returns; downside if growth stalls. |
Q2 FY2026 Key Data (Apr-Jun 2026), reported 2026.07.22
- Revenue $17.2B (+1% cc); operating EPS $2.93 (+5%), pre-tax margin 19.2%; GAAP EPS $2.27.
- MISS: ~tens of large mainframe/ELA deals slipped (CapEx redirect); Software +5% (ARR $24.6B), Infra −7%, Consulting +1%.
- FY guide cut to +4–5% cc but 100bps operating-margin expansion + FCF +$1B held; deferred, not lost.
Key Takeaways from Earnings Call
- The miss was deal-timing and execution, not lost demand. ~Tens of large mainframe/ELA deals slipped in late June as clients redirected CapEx to servers, storage, and memory ahead of price hikes. About a third already re-closed in the first three weeks of Q3, and IBM expects most of the rest over six months. These are mission-critical workloads with a 2–15x TCO advantage and no evidence of clients leaving the mainframe.
- Recurring software carried the quarter. ~80% of software revenue is recurring and grew nicely: Red Hat +11% (OpenShift ARR $2.2B), Data +18% cc, total ARR $24.6B (+8%), HashiCorp record bookings, Confluent on track. Weakness was concentrated in the ~20% transactional, mainframe-linked ELA software (Transaction Processing −9%) that is CapEx-sensitive — the piece that slipped.
- Margin and FCF discipline stayed intact. Productivity actions ran ahead of plan, expanding operating pre-tax margin 30bps despite the revenue shortfall. FY guide now calls for 100bps of operating-margin expansion and FCF growth of ~$1B (H1 FCF $4.8B, flat YoY). The ~4% dividend ($1.69/qtr) and investment-grade balance sheet (cash $8.2B) are unchanged.
- AI plus quantum optionality is the long game. watsonx Orchestrate is the agentic control plane atop Red Hat; z17 is the best cycle on record (~130% program-to-program) with ~50% of buyers adding Spyre AI accelerators. Quantum: $10B+ over five years, the Anderon foundry, a roadmap to fault-tolerant quantum by 2029, and IDC’s #1 ranking. New Lightwell open-source security ($1M/yr) is already adopted by major banks.
Key Segments and Revenue Mix (Q2 FY2026)
| Segment | Q2 2026 Revenue | % of Total | Key Details |
|---|---|---|---|
| Software | $7,761M | 45% | +5%. Red Hat/Hybrid Cloud +11%, Data +18% cc, Automation +3%, Transaction Processing −9%. ARR $24.6B (+8%); ~80% recurring. |
| Consulting | $5,327M | 31% | +1% cc. Signings +6%; GenAI ~50% of signings, >30% of backlog. |
| Infrastructure | $3,835M | 22% | −7%. IBM Z −42% (deals slipped) but z17 ~130% prog-to-prog; Distributed Infra +37% record, $500M backlog. |
| Financing | $186M | 1% | Captive financing; 80% investment-grade receivables portfolio. |
Key metrics: Software ARR $24.6B (+10%). Red Hat OpenShift $2B ARR. Virtualization contracts $600M+ since 2024. GenAI book of business $6B+ cumulative. Consulting backlog ~30% GenAI. Z17 outperforming all prior programs. Cash $11.8B. Key competitors: Microsoft, Oracle, Accenture, ServiceNow, Salesforce.
Business Model
SUPPLIERS
Open-source communities (Linux, K8s)
Semiconductor R&D (Z processors)
AI research (foundation models)
Acquisitions (Confluent, HashiCorp)
Technology /
IP
→
IBM
Software (Red Hat, watsonx, Data, Automation)
Consulting (strategy, app modernization)
Infrastructure (Z mainframe, Power, Storage)
Security (Concert, QRadar)
$24.6B Software ARR, 6B+ GenAI book
Platform /
Services
→
$ Revenue
CUSTOMERS
Banks & financial services
Healthcare & life sciences
Government & defense
Telecommunications
Manufacturing & retail
Moat Assessment: NARROW
- Mission-critical entrenchment in financial services and government: IBM Z processes billions of transactions daily for the world’s largest banks with 6-8 nines of availability. Moving off mainframe is a multi-year, multi-billion dollar project that most clients won’t undertake. This creates deep lock-in, but it’s also a declining addressable market without new workload migration.
- Red Hat and open-source platform positioning: Red Hat provides the common platform for running applications across any cloud or on-premise environment. OpenShift at $2B ARR is becoming the enterprise standard for Kubernetes. Open-source reduces vendor lock-in risk, but IBM monetizes through support, security, and enterprise features that are hard to replicate.
- Consulting relationships create cross-sell opportunity but face commoditization risk: IBM’s consulting sits side-by-side with its software, creating a unique integrated value proposition. But consulting is fundamentally a people business where AI-driven productivity could reduce billable hours. The shift to asset-led delivery (Consulting Advantage Platform) is necessary but unproven at scale.
Stock vs. Earnings — 5-Year Performance
- Stock currently at $206, up ~47% from ~$140 (5 years ago). The appreciation reflects IBM’s transformation into a software-led platform business. The 2024 AI-narrative breakout gave back ground on the Q2 2026 pre-announcement.
- TTM OP grew ~47% from ~$9.0B to $13.2B (operating non-GAAP basis). Driven by portfolio shift toward higher-margin software (now ~45% of revenue), the Z17 mainframe cycle, and cumulative productivity savings.
- P/E(ttm) at 17x sits in line with IBM’s historically stable range (~9-28x, typically 16-17x), so the multiple has not re-rated even as earnings grew. Still modest compared to enterprise software peers (30-40x).
Past 5-Year Key Drivers
- Portfolio transformation to software-led model: IBM divested managed infrastructure (Kyndryl spin-off 2021) and pivoted to software through acquisitions (Red Hat, HashiCorp, Confluent, DataStax). Software is now ~40% of revenue.
- AI-enabled productivity engine generating $1B+ annual savings: $4.5B cumulative savings since 2023 through automation, AI, and process simplification. IBM Bob delivering 45% developer productivity gains.
- Z mainframe cycle providing infrastructure earnings boost: Z17 is the strongest mainframe cycle ever, with +48% growth in Q4 of the cycle. Clients growing MIPS 3x faster with watsonx Code Assistant.
Quarterly Key Metrics
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026E | |
|---|---|---|---|---|---|---|---|---|---|---|
| Quarter End | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
| Stock Price | $175 | $221 | $220 | $249 | $295 | $282 | $296 | $242 | $281 | $206 |
| Stock QoQ | -8% | +26% | -1% | +13% | +19% | -4% | +5% | -18% | +16% | -27% |
| Rev YoY | 2% | 1% | 1% | 1% | 8% | 9% | 12% | 9% | 1% | 3% |
| OM% | 18% | 17% | 24% | 12% | 19% | 19% | 24% | 13% | 19% | 19% |
| R40 (Rev YoY + OM%) | 20% | 18% | 25% | 12% | 26% | 28% | 36% | 23% | 20% | 22% |
| TTM OP ($M) | $10,916 | $11,104 | $11,208 | $11,288 | $11,693 | $12,239 | $12,713 | $13,104 | $13,197 | $13,291 |
| TTM OP QoQ | +4% | +2% | +1% | +1% | +4% | +5% | +4% | +3% | +1% | +1% |
| FCF/OP ttm | 110% | 107% | 104% | 105% | 99% | 93% | 85% | 89% | 97% | 101% |
| Debt/EBITDA | 3.4x | 3.1x | 3.0x | 3.4x | 3.3x | 3.2x | 3.0x | 3.2x | 3.1x | 3.1x |
| P/E ttm | 17x | 21x | 21x | 24x | 28x | 26x | 26x | 20x | 23x | 17x |
Recent Stock Performance & Drivers
- Stock at ~$206 vs ~$242 (Apr 2026). The headline move is the ~27% drop from the ~$281 June-30 close after IBM pre-announced a Q2 miss — tens of large mainframe/ELA deals slipped. Management calls it deferred, not lost.
- TTM OP grew from $10,651M to $13.2B (+18%) over 7 quarters, driven by software mix shift, Z17 contribution, and $1B+ annual productivity savings. FCF/OP consistently in the 80-89% range, demonstrating high-quality earnings conversion.
- P/E(ttm) at 17x is modest for a cash-generative, dividend-paying name. The discount reflects consulting exposure (~31%), low-single-digit growth, and the Q2 stumble. If software re-accelerates toward its 6–8% guide, the multiple could re-rate.
Opportunities
- AI orchestration and governance is IBM’s lane. watsonx Orchestrate is the agentic control plane; with Red Hat’s neutrality, IBM adds observability, governance, and security to run agents across models, clouds, and on-prem.
- Recurring software compounds. ~80% of software revenue is recurring; ARR $24.6B (+8%). Red Hat +11% (OpenShift ARR $2.2B), Data +18% cc, HashiCorp record bookings, Confluent ramping — supporting a long-term double-digit software ambition.
- Quantum and mainframe-AI optionality. z17 is the best cycle on record; ~50% of buyers add Spyre AI accelerators. IBM is putting $10B+ into quantum toward fault-tolerance by 2029 (IDC #1); Lightwell opens a multi-billion open-source-security TAM.
Challenges
- Execution and deal-timing risk. The Q2 miss came from ~tens of large ELA/mainframe deals slipping in June — lumpy, CapEx-sensitive, quarter-end-weighted deals make results hard to forecast.
- Slow growth plus mainframe cyclicality. Even after the guide, revenue grows only ~4–5%, and the transactional mainframe stack (Transaction Processing −9%, IBM Z −42%) swings hard with the product cycle.
- Competition and an unproven thesis. The AI-orchestration/governance bet competes with hyperscalers, Microsoft, and ServiceNow, and is unproven at scale. If AI compresses consulting hours faster than new demand arrives, the mix turns into a headwind.
Next 12 Months
- Re-closing slipped deals; delivering FY +4–5% cc. A third of slipped deals re-closed in early Q3; the low end (+4%) is the base case, the high end assumes normal pipeline conversion. Q3 cc growth is ~consistent with the year.
- Margin and cash discipline. Productivity actions (AI in software dev, sales/marketing efficiency, supply chain) run ahead of plan, funding 100bps of operating pre-tax margin expansion and FCF growth of ~$1B, with the dividend intact.
- z17 cycle and Distributed Infrastructure momentum. z17 remains ~130% program-to-program; Distributed Infrastructure grew 37% (record) with a $500M backlog. Infrastructure is guided to low-single-digit growth as Power and Storage demand stays strong.
Next 12-24 Months
- The AI-orchestration book scales from pilots to production. As enterprises deploy agents, watsonx Orchestrate plus Red Hat could turn IBM’s consulting-plus-software position into a durable, recurring orchestration franchise.
- Quantum roadmap toward fault-tolerance. IBM targets the first large-scale, fault-tolerant quantum computer in 2029, backed by $10B+ and the Anderon foundry. Not near-term revenue, but milestones would expand IBM’s technology premium.
- Recurring mix shift keeps lifting quality. Red Hat, HashiCorp, and Confluent push the software mix toward subscription/consumption (from ~60/40 to 80/20 recurring), expanding margins and FCF durability and supporting a re-rating over time.
Core Metrics Scorecard
| Q4'21 | Q1'22 | Q2'22 | Q3'22 | Q4'22 | Q1'23 | Q2'23 | Q3'23 | Q4'23 | Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26E | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quarter End | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | Jun26 | Sep26 |
| R40 > 40% | ||||||||||||||||||||
| R40 accelerate | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | |||||||
| TTM OP QoQ > 10% | ✅ | |||||||||||||||||||
| TTM OP QoQ accelerate | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | |||||||||||||
| TTM FCF/OP > 60% | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
| Debt/EBITDA < 3.5 | ✅ | ✅ | ✅ | ✅ | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
| Total passes | 5 | 3 | 4 | 2 | 4 | 1 | 2 | 3 | 2 | 1 | 4 | 2 | 3 | 2 | 4 | 4 | 3 | 2 | 2 | 3 |
| Stock QoQ | +1% | -3% | +9% | -16% | +19% | -7% | +2% | +5% | +15% | +18% | -8% | +26% | -1% | +13% | +19% | -4% | +5% | -18% | +16% | -27% |
| P/E ttm | 13x | 14x | 15x | 13x | 15x | 14x | 15x | 15x | 17x | 19x | 17x | 21x | 21x | 24x | 28x | 26x | 26x | 20x | 23x | 17x |
Note: IBM’s low revenue growth rate means R40 never exceeds 40% and TTM OP QoQ rarely exceeds 10%. The scorecard captures financial health and directional improvement more than absolute growth levels.
- The scorecard reads 2/6 in Q2 2026, and the stock fell ~27% on the miss — breaking the old rally pattern. R40 never passes (~high-20s% on low-single-digit growth + ~19% margin) and TTM OP QoQ >10% rarely does; FCF/OP and low leverage anchor the score.
- Debt/EBITDA started failing (above 3.5x) through Q1 2024 due to acquisition-driven leverage, then passed from Q2 2024 onward as earnings grew and debt stabilized. The current 3.0x is manageable but elevated post-Confluent.
Chart: R40 vs Stock Price (Since 2020)
Chart: Scorecard Total Passes vs Stock Price (Since 2020)
Q1 FY2026 Key Data, reported 2026.04.22
- Revenue $15.9B (+6% CC), beat expectations. Adj EPS +19%. FCF $2.2B (+13%), highest Q1 in a decade.
- By segment: Software $6.3B (+8%, Red Hat +10%, Data +16%), Consulting $5.1B (+2%), Infrastructure $3.1B (+5%).
- FY2026 guide reaffirmed: mid-single-digit CC revenue growth, $13.5B+ FCF. Confluent integration on track.
Key Takeaways from Earnings Call
- IBM positioning as “AI control plane” — 96% of software is enabling/infrastructure (not applications), making AI a structural tailwind. AI platform (agents, assistants, orchestration) already $1.5B+ ARR growing 40%+, contributing 2pts of software growth. Confluent adds live data streaming. Software raised to 10%+ for FY2026. M&A appetite increasing — Arvind called current valuations “very attractive,” possible H2 deals.
- Z17 strongest cycle ever: MIPS shipped 100%+ growth for 4 consecutive quarters, hardware placement value +$1B vs Z16 (with 3-4x stack multiplier for future monetization). Spyre enables 450B AI inferences/day at 1ms. Clients with watsonx Code Assistant growing MIPS 3x faster. Fraud detection on 100% of transactions saving tens of millions. TCO advantage 3-15x vs cloud.
- Consulting inflecting with $4B+ GenAI ARR (80% from net new clients, 400 new clients in Q1). Signings +6%, backlog yields +4pts YoY. Middle East “strongest growth in decades.” Europe also strong, no deal slowdowns. Productivity savings targeting $5.5B run-rate exiting 2026. Guidance maintained (not raised) due to prudence — CFO: “Never raised guidance after Q1 in 9 years.”
Source: SEC EDGAR annual and quarterly filings, company earnings conference calls and presentations.
Disclaimer: This report is for educational purposes only. NO investment advice.